Innospec Inc. (IOSP) Stock Price & Analysis
Innospec Inc. (IOSP) closed at USD 100.7 on Wednesday, October 28, 2026, up 0.78% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 99.92; the Oct 28, 2026 session ranged USD 99–100.75 on volume of 145,374 shares. Market capitalization is $2.48B, with a 52-week range of USD 65.51–100.76 (NMS). Source: Nexqual, retrieved October 29, 2026 at 07:12 UTC.
Also available as compact Markdown for AI agents: nexqual.com/IOSP.md
Key facts (IOSP)
- Last four reported quarters (through Jun 30, 2026): revenue $1.84B, net income $122M (6.6% margin), free cash flow $68.8M (SEC filings).
- Valuation: P/E 20.4x (avg 38.8x at the last 3 fiscal year-ends).
- Analysts: Buy (mean 1.67 on a 1–5 scale) (3 analysts), mean target USD 101 (range 93–110).
- Total return with dividends: 1Y +40.4% vs S&P 500 +13.6%; 5Y +20.1% vs S&P 500 +79.8%.
- Next earnings: 2026-11-03, EPS estimate USD 1.26, revenue estimate $479M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (IOSP)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.48B | $1.96B | $1.95B | $1.85B | $1.78B | $1.84B |
| Gross profit | $435M | $587M | $591M | $543M | $492M | — |
| Operating income | $132M | $187M | $162M | $178M | $130M | $129M |
| Net income | $93.1M | $133M | $139M | $35.6M | $117M | $122M |
| EPS (diluted) | $3.75 | $5.32 | $5.56 | $1.42 | $4.67 | — |
| Free cash flow | $54.1M | $42.1M | $145M | $143M | $88.0M | $68.8M |
| Gross margin | 29.3% | 29.9% | 30.3% | 29.4% | 27.7% | — |
| Operating margin | 8.9% | 9.5% | 8.3% | 9.6% | 7.3% | 7.0% |
| Net margin | 6.3% | 6.8% | 7.1% | 1.9% | 6.6% | 6.6% |
| Revenue growth | +24.3% | +32.4% | -0.8% | -5.3% | -3.7% | — |
| Cash + short-term investments | $142M | $147M | $204M | $289M | $293M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (IOSP)
P/E 20.4x · P/S 1.4x · P/FCF 36.1x · P/B 1.9x · FCF yield 2.77% · Earnings yield 4.90% · Buyback yield (TTM) 0.97%
P/E at fiscal year-ends: Dec 2025 16.4x, Dec 2024 77.7x, Dec 2023 22.2x.
Analysts (IOSP)
Consensus Buy (mean 1.67 on a 1–5 scale), 3 analysts; mean target USD 101 (low 93, high 110).
Total return (dividends reinvested) (IOSP)
| 1Y (from 2025-10-29) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +40.4% | +20.1% |
| S&P 500 (SPY) | +13.6% | +79.8% |
| Per year | +40.5% | +3.7% |
| Volatility (annualized) | 23.0% | 27.0% |
| Max drawdown | -25.5% (Feb 2026→Mar 2026) | -48.2% (May 2024→Mar 2026) |
IOSP earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| Aug 5, 2026 | Quarter ended Jun 30, 2026 | $1.27 | $1.05 | Beat +21.0% | +5.6% |
| May 8, 2026 | Quarter ended Mar 31, 2026 | $1.05 | $1.01 | Beat +4.0% | +5.5% |
| Feb 18, 2026 | Quarter ended Dec 31, 2025 | $1.50 | $1.24 | Beat +21.0% | -4.0% |
| Nov 5, 2025 | Quarter ended Sep 30, 2025 | $1.12 | $1.06 | Beat +5.7% | +1.7% |
| Aug 6, 2025 | — | — | — | — | -1.1% |
| May 9, 2025 | — | — | — | — | -2.9% |
| Feb 19, 2025 | — | — | — | — | -6.1% |
| Nov 6, 2024 | — | — | — | — | +8.0% |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
IOSP recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Oct 7, 2026 | Schedule 13G/A | Allspring Global Investments Holdings, LLC: 4.7% of shares, passive 5%+ holder (amended) |
| Oct 7, 2026 | Schedule 13G | Allspring Global Investments Holdings, LLC: 4.7% of shares, passive 5%+ holder |
| Aug 5, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
| Aug 5, 2026 | 8-K | Quarterly results |
| Jul 31, 2026 | Schedule 13G/A | Allspring Global Investments Holdings, LLC: 7.7% of shares, passive 5%+ holder (amended) |
| Jul 14, 2026 | Schedule 13G | Dimensional Fund Advisors LP: 5.3% of shares, passive 5%+ holder |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
IOSP revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Performance Chemicals | $190.3M | 38.7% | +9.5% |
| Fuel Specialties | $185.7M | 37.8% | +12.5% |
| Oilfield Services | $115.4M | 23.5% | +14.5% |
| Total revenue | $491.4M | 100% | — |
IOSP revenue by region (fiscal year ended Dec 31, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| United States | $951.7M | 53.5% | -8.5% |
| United Kingdom | $793.2M | 44.6% | -3.7% |
| Rest Of World | $379.0M | 21.3% | +31.2% |
| Total revenue | $1.78B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
IOSP company outlook (results filed Aug 5, 2026)
- “We expect these combined efforts to drive further improvement in the second half of 2026.”
Quoted word-for-word from the SEC 8-K results press release.
IOSP analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.26 | $1.26 | +0.3% | $479.2M | 3 |
| Next quarter (ends Dec 2026) | $1.41 | $1.45 | -2.8% | $496.4M | 3 |
| Current fiscal year (ends Dec 2026) | $4.92 | $4.81 | +2.4% | $1.91B | 3 |
| Next fiscal year (ends Dec 2027) | $6.17 | $6.08 | +1.4% | $2.02B | 3 |
IOSP options: expected move
Options price a move of about ±6.0% (±$6.05) by Nov 20, 2026, which includes earnings on Nov 3, 2026. Over the last 8 reports the stock moved ±4.4% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 23 | 28.6% | ±6.0% |
| Dec 18, 2026 | 51 | 23.6% | ±7.0% |
| Mar 19, 2027 | 142 | 25.0% | ±12.4% |
| Jun 17, 2027 | 232 | 25.4% | ±16.0% |
30-day implied volatility 27.5% vs 19.1% realized over the last 30 trading days. Put/call ratio (volume) —. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 29, 2026 at 07:12 UTC)
| Price | USD 100.7 |
|---|---|
| Change | ▲ 0.78% (up) |
| Previous Close | USD 99.92 |
| Open | USD 99.83 |
| Day Range | USD 99 – 100.75 |
| 52-Week Range | USD 65.51 – 100.76 |
| Volume | 145,374 shares |
| Market Cap | $2.48B |
| Exchange | NMS |
Technical Analysis (IOSP)
Nexqual's technical model rates IOSP "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 29, 2026 at 07:12 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 67.08 (neutral) |
| vs SMA50 | Above (USD 95.74) |
| MACD | 1.26 (positive) |
Analyst Ratings (IOSP)
Wall Street analysts rate IOSP "Buy" based on 3 analysts, with a mean price target of USD 101 (range USD 93–110), per Nexqual as of October 29, 2026 at 07:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 101 |
| High Target | USD 110 |
| Low Target | USD 93 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (IOSP)
| Next Earnings Date | 2026-11-03 |
|---|---|
| EPS Estimate | USD 1.26 |
| Revenue Estimate | $479.17M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.27 vs est 1.05 ▲ beat |
| 2026-03-31 | USD 1.05 vs est 1.02 ▲ beat |
| 2025-12-31 | USD 1.5 vs est 1.24 ▲ beat |
| 2025-09-30 | USD 1.12 vs est 1.06 ▲ beat |
Source: Nexqual, October 29, 2026 at 07:12 UTC.
Financials & Fundamentals (IOSP)
| Total Revenue | $1.84B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +11.80% |
| Gross Margin | +27.46% |
| Operating Margin | +8.08% |
| Profit Margin | +6.60% |
| ROE | +9.13% |
| Debt / Equity | 0.04 |
| Current Ratio | 2.78 |
| Total Cash | $250.20M |
| Total Debt | $47.90M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $68.80M (3.7% of revenue) |
Source: Nexqual, October 29, 2026 at 07:12 UTC.
Financial Health Score (IOSP)
Nexqual rates Innospec Inc.'s overall financial health "Mixed" across five dimensions, as of October 29, 2026 at 07:12 UTC.
| Growth | Weak — Revenue -4% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 27%, operating 7% (last 4 quarters to Jun 2026, SEC) |
| Balance Sheet | Strong — $250M cash vs $48M debt, net cash position |
| Cash Flow | Mixed — FCF $69M (last 4 quarters to Jun 2026, SEC), slim 3.7% margin |
| Efficiency | Mixed — ROE 9%, ROA 6.6% (last 4 quarters, SEC) |
Ownership (IOSP)
| Insider Ownership | +1.35% |
|---|---|
| Institutional Ownership | +100.84% |
| Shares Outstanding | 24.63M |
| Float | 24.32M |
| Short % of Float | +2.72% |
Source: Nexqual, October 29, 2026 at 07:12 UTC.
Leadership (IOSP)
Innospec Inc. is led by Patrick S. Williams, President, CEO & Director, per Nexqual as of October 29, 2026 at 07:12 UTC.
| President, CEO & Director | Patrick S. Williams |
|---|---|
| Executive VP & CFO | Ian Philip Cleminson |
| CTO and Senior VP of Research & Technology | Ian M. McRobbie |
| Senior Vice President of Corporate Development & Investor Relations | Corbin Barnes |
| Senior Vice President of Human Resources | Trey Griffin |
Major Backers & Investors (IOSP)
Notable institutional backers of Innospec Inc. include Allspring Global Investments Holdings, LLC, ALLSPRING FUNDS TRUST-Allspring Special Small Cap Value Fund, Goldman Sachs, according to Nexqual as of October 29, 2026 at 07:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Allspring Global Investments Holdings, LLC | 7.68% |
| ALLSPRING FUNDS TRUST-Allspring Special Small Cap Value Fund | 3.68% |
| Goldman Sachs | 2.69% |
| Victory Capital Management Inc. | 2.68% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 17.79% |
| Vanguard Group | 12.15% |
| Dimensional Fund Advisors | 5.3% |
| State Street | 4.04% |
| Nuveen | 3.07% |
| Geode Capital | 2.71% |
Source: Nexqual, October 29, 2026 at 07:12 UTC.
From Innospec Inc.'s Latest SEC 10-K Filing (filed 2026-02-18)
Key Strengths & Strategy (as disclosed to the SEC)
- We focus on opportunities that would extend our technology base, geographical coverage or product portfolio.
Partnerships
- We encourage and welcome feedback and we support people to deal with any unwelcome messages.
Legal & Regulatory Risks (Item 1A, quoted)
- We are subject to extensive regulation of our international operations that could adversely affect our business and results of operations.
- Legal proceedings and other claims could impose substantial costs on us.
- Environmental liabilities and compliance costs could have a substantial adverse impact on our results of operations.
- Our operations, and the operations of prior owners of our sites, pose the risk of environmental contamination which may result in fines or criminal sanctions being imposed or require significant amounts in environmental remediation payments.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCPC | Balchem Corporation | USD 166.3 | ▼ 1.42% |
| SXT | Sensient Technologies Corporati | USD 131.59 | ▼ 0.23% |
| AXTA | Axalta Coating Systems Ltd. | USD 34.64 | ▲ 0.35% |
| EMN | Eastman Chemical Company | USD 66.67 | ▲ 0.83% |
| NEU | NewMarket Corp | USD 873.27 | ▼ 0.25% |
| WLK | Westlake Corporation | USD 65.83 | ▼ 0.51% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 07:12 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt